수술실용 장비 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the operating room equipment market size is projected to expand from USD 48.72 billion in 2025 and USD 51.10 billion in 2026 to USD 64.87 billion by 2031, registering a CAGR of 4.89% between 2026 to 2031.

This report is Segmented by Product (Anesthesia Devices, Surgical Imaging Systems, and More), Mobility (Fixed/In-built, Modular/Retrofit, Mobile/Portable), End User (Hospitals, Ambulatory Surgical Centers, and More), Surgical Specialty (General Surgery, Orthopedic Surgery, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Operating Room Equipment Market Trends and Insights

Growing Incidence of Chronic Diseases Requiring Surgeries

Escalating prevalence of cardiovascular, oncologic, and metabolic disorders is raising the annual global surgical volume, stretching legacy OR infrastructure and catalyzing procurement plans aimed at cutting turnover time and anesthesia exposure. Aging populations in the United States, Germany, Japan, and China have pushed average surgical case complexity higher, favoring hybrid rooms equipped with integrated CT or angiography. Hospitals are purchasing advanced patient monitors that stream physiologic data directly into electronic health records, aiding chronic-condition management and postoperative follow-up. The long-term demand curve therefore aligns squarely with demographic trends rather than economic cycles. Vendors that bundle perioperative analytics and consumables with durable hardware are positioned to capture wallet share as chronic-disease caseloads rise.

Post-Pandemic Elective-Surgery Backlog Accelerating OR Upgrades

NHS England reported 7.57 million open pathways as of September 2024, roughly double pre-pandemic volume and a level that continues to strain evening and weekend OR sessions. Similar bottlenecks in France and the United States are exposing limits of older anesthesia workstations whose maintenance cycles were never designed for extended hours. To keep pace, health ministries released targeted capital grants-the United Kingdom ring-fenced GBP 1.5 billion for theater modernization in FY 2024-2025-while hospitals negotiated lease-to-own financing that preserves cash flow yet accelerates equipment refresh. Semiconductor shortages dragged delivery timelines to 18-24 months during 2024, but inventories normalized in early 2026, enabling vendors to clear backorders and generate a revenue spike that should taper by 2027 when waiting lists normalize. Because backlogs are temporary, manufacturers emphasize modular upgrades that install in days, avoiding decade-long commitments that may outlast deferred-care surges.

High Capital & Maintenance Costs of OR Equipment

A fully integrated hybrid suite costs USD 5-8 million, and annual service contracts add 8-12% of purchase price, squeezing community hospitals that run on sub-5% operating margins. Leasing eases upfront outlay but shifts residual-value risk to suppliers, who must guess depreciation in a market where imaging software releases every 18 months. India's General Financial Rules split tenders above INR 2.5 million, undermining volume discounts and inflating per-unit prices by 10-15%. In Latin America, import tariffs tack on another 20-30%, forcing facilities to stretch assets well past recommended lifespan. Because capital scarcity is structural, vendors see opportunity in modular add-ons and certified refurbishment programs that lower entry thresholds without sacrificing clinical performance.

Other drivers and restraints analyzed in the detailed report include:

1. Increasing Adoption of Minimally Invasive & Image-Guided Surgeries
2. Carbon-Neutral Procurement Mandates Driving LED & Low-Energy OR Retrofits
3. EU-MDR 2027 Re-Certification Bottleneck Delaying Device Refresh Cycles

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Anesthesia devices accounted for 54.54% of operating room equipment market share in 2025, owing to mature installed bases and strict gas-delivery regulations. Low-flow workstations that cut volatile-anesthetic use by up to 50% are winning tenders as hospitals chase carbon targets and cost savings. In contrast, surgical imaging systems, from mobile cone-beam CT to intraoperative MRI, are expanding at 10.25% CAGR; this pace lifts the operating room equipment market size attributed to imaging far faster than aggregate growth. Electrosurgical units, tables, and lights trail with mid-single-digit gains, though mandated smoke evacuation in Colorado, Rhode Island, and Oregon is reviving demand for specialized suction systems.

Growth dynamics signal a capital-allocation rebalance. Hospitals favor procedure-enabling technologies such as imaging and navigation over infrastructure staples like anesthesia that can be leased or maintained through long-term service. GE HealthCare's OEC 3D mobile C-arm, cleared by FDA in 2024, delivers hybrid-suite imaging at 60% lower capital cost, aligning with modular spending patterns. Meanwhile, strict FDA and ISO standards keep anesthesia-device innovation slow, preserving share but capping upside. Collectively, these diverging trajectories ensure the operating room equipment market remains heterogeneous across product lines.

Fixed installations held 57.54% of 2025 revenue, cemented in new-build hospitals that embed booms, laminar-flow ceilings, and gas pipelines from day one. Yet modular and retrofit solutions are forecast to rise 7.65% annually, capturing capital redirected from shelved tower projects into phased upgrades that minimize downtime. This shift enlarges the operating room equipment market size attributed to modular packages while trimming average project costs per square foot.

Getinge's Maquet Moduevo can be installed in 48 hours, versus six weeks for traditional builds, saving hospitals roughly USD 10,000 in lost procedure revenue per day. Mobile equipment sees modest uptake in ASCs and disaster-relief settings, but infection-control rules-ISO 14644 cleanroom grades-favor fixed assets with flush surfaces. As greenfield hospital spending decelerates across OECD countries, retrofit providers will shoulder a greater portion of the operating room equipment market, tightening competition on lead-time, installation cost, and maintenance guarantees.

Complete Report Scope:

• By Product
  • Anesthesia Devices
  • Surgical Imaging Systems
  • Electrosurgical Devices
  • Operating Tables
  • Surgical & Exam Lights
  • Patient Monitors
  • Medical Pendants & Booms
  • Smoke Evacuation Systems
  • Other OR Equipment
• By Mobility
  • Fixed / In-built
  • Modular / Retrofit
  • Mobile / Portable
• By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Out-patient Facilities / Specialty Clinics
• By Surgical Specialty
  • General Surgery
  • Orthopedic Surgery
  • Cardiovascular Surgery
  • Neurosurgery
  • Gynecology & Urology
  • ENT & Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America, with 39.23% revenue share in 2025, maintains leadership on the back of Medicare Advantage penetration exceeding 50% of eligible lives and ASC density of one center per 60,000 residents in states such as Florida and Texas. Hospitals in the region continue to replace halogen lights and legacy anesthesia workstations to comply with state carbon targets in California and New York, adding momentum to the operating room equipment market. Cybersecurity-insurance premiums for connected OR platforms, however, jumped 18% year-on-year in 2025, nudging facilities to delay networked-device rollouts until hardening policies are in place. Canada tracks a similar pattern but at smaller scale, with provincial bulk-buy programs extending tender cycles to 24 months.

Asia-Pacific is projected to grow at 6.12% through 2031 as China's 14th Five-Year Plan assigns CNY 200 billion (USD 28 billion) to hospital construction and India's Production-Linked Incentive scheme offers 5% subsidies on domestically made devices. Chinese surgical-robot installations climbed 35% in 2024 to about 400 units, aided by domestic vendors pricing 40-50% below Western rivals. India's split market sees metro private chains importing premium U.S. and EU brands, while tier-2 public facilities rely on local manufacturers to meet make-in-India quotas. Japan's aging populace drives demand for minimally invasive suites, yet strict fee schedules cap margins, so hospitals negotiate equipment-as-a-service deals to spread cost.

Europe displays a two-speed trajectory. Western markets face austerity budgets and EU MDR re-certification frictions that extend device life beyond planned cycles, softening short-term demand. Eastern members such as Poland and Romania leverage EU Cohesion Funds to retrofit ORs, expanding regional share of the operating room equipment market. In the Middle East, Saudi Arabia's Vision 2030 healthcare pillar funds 40 new hospitals that embed bilingual visualization interfaces for medical tourism. South America hinges on Brazil, where Sistema Unico de Saude upgrades 1,200 public ORs with LED lights and low-flow anesthesia; tariff-inflated prices slow momentum elsewhere on the continent. Together these regional narratives keep overall operating room equipment market growth resilient despite local idiosyncrasies.

1. Baxter
2. Conmed
3. Dragerwerk
4. GE Healthcare
5. Getinge
6. Intuitive Surgical
7. Karl Storz
8. Koninklijke Philips
9. Medtronic
10. Mindray
11. Olympus
12. Siemens Healthineers
13. Skytron
14. Smiths Group
15. STERIS
16. Stryker
17. Zimmer Biomet

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing incidence of chronic diseases requiring surgeries
  • 4.2.2 Rising number of hospitals & government funding
  • 4.2.3 Increasing adoption of minimally-invasive & image-guided surgeries
  • 4.2.4 Post-pandemic elective-surgery backlog accelerating OR upgrades
  • 4.2.5 Carbon-neutral procurement mandates driving LED & low-energy OR retrofits
  • 4.2.6 SaaS-based surgical-visualization subscriptions enabling mid-tier upgrades
• 4.3 Market Restraints
  • 4.3.1 High capital & maintenance costs of OR equipment
  • 4.3.2 Shortage of skilled peri-operative personnel
  • 4.3.3 Escalating cybersecurity-insurance premiums for connected OR platforms
  • 4.3.4 EU-MDR 2027 re-certification bottleneck delaying device refresh cycles
• 4.4 Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product
  • 5.1.1 Anesthesia Devices
  • 5.1.2 Surgical Imaging Systems
  • 5.1.3 Electrosurgical Devices
  • 5.1.4 Operating Tables
  • 5.1.5 Surgical & Exam Lights
  • 5.1.6 Patient Monitors
  • 5.1.7 Medical Pendants & Booms
  • 5.1.8 Smoke Evacuation Systems
  • 5.1.9 Other OR Equipment
• 5.2 By Mobility
  • 5.2.1 Fixed / In-built
  • 5.2.2 Modular / Retrofit
  • 5.2.3 Mobile / Portable
• 5.3 By End User
  • 5.3.1 Hospitals
  • 5.3.2 Ambulatory Surgical Centers
  • 5.3.3 Out-patient Facilities / Specialty Clinics
• 5.4 By Surgical Specialty
  • 5.4.1 General Surgery
  • 5.4.2 Orthopedic Surgery
  • 5.4.3 Cardiovascular Surgery
  • 5.4.4 Neurosurgery
  • 5.4.5 Gynecology & Urology
  • 5.4.6 ENT & Others
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 Baxter International Inc.
  • 6.3.2 Conmed Corporation
  • 6.3.3 Dragerwerk AG & Co. KGaA
  • 6.3.4 GE HealthCare
  • 6.3.5 Getinge AB
  • 6.3.6 Intuitive Surgical Inc.
  • 6.3.7 Karl Storz SE & Co. KG
  • 6.3.8 Koninklijke Philips N.V.
  • 6.3.9 Medtronic plc
  • 6.3.10 Mindray Medical International
  • 6.3.11 Olympus Corporation
  • 6.3.12 Siemens Healthineers AG
  • 6.3.13 Skytron LLC
  • 6.3.14 Smith & Nephew plc
  • 6.3.15 STERIS plc
  • 6.3.16 Stryker Corporation
  • 6.3.17 Zimmer Biomet Holdings Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment